PGRMC2 and ischemic stroke: The intraperitoneal injection of CPAG‐1, a gain‐of‐function ligand of PGRMC2, conferred resistance to BBB leakage, astrocyte activation, microglial activation, neuronal death, and disruption of neuroplasticity while promoting the recovery of sensorimotor dysfunctions after ischemic stroke.